Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  BB BIOTECH AG    BION   CH0038389992

BB BIOTECH AG (BION)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
06/12/2018 06/13/2018 06/14/2018 06/15/2018 06/18/2018 Date
66.5(c) 67.2(c) 67.6(c) 66.65(c) 65.55 Last
80 012 63 459 58 615 70 135 34 022 Volume
0.00% +1.05% +0.60% -1.41% -1.65% Change
More quotes
Financials (CHF)
Sales 2018 -
EBIT 2018 444 M
Net income 2018 444 M
Debt 2018 289 M
Yield 2018 4,65%
Sales 2019 8,32 M
EBIT 2019 457 M
Net income 2019 459 M
Debt 2019 323 M
Yield 2019 3,71%
P/E ratio 2018 8,15
P/E ratio 2019 7,80
EV / Sales2018 0
EV / Sales2019 483x
Capitalization 3 692 M
More Financials
Company
BB Biotech AG is a closed-end investment fund, which engages in investing in biotechnology companies.It focuses on companies whose products address areas of significant unmet medical needs and generates above-average sales and profit growth.The company was founded on November 9, 1993 and is... 
Sector
Biotechnology & Medical Research
Calendar
07/20 | 07:00amEarnings Release
More about the company
Surperformance© ratings of BB BIOTECH AG
Trading Rating : - Investor Rating :
More Ratings
Latest news on BB BIOTECH AG
04/23BB BIOTECH AG : Notification and public disclosure of transactions by persons
EQ
04/23BB BIOTECH AG : Notification and public disclosure of transactions by persons
EQ
04/20BB BIOTECH : share gains value in first quarter 2018 - several large-cap biotech..
EQ
03/15BB BIOTECH AG : Ex-dividend day for final dividend
FA
03/13BB BIOTECH AG : Shareholders at the general meeting vote in favor of all proposa..
EQ
02/16BB BIOTECH : publishes its 2017 annual report
EQ
01/19BB BIOTECH : shows a double-digit total return for 2017 - mid caps overdeliver o..
EQ
2017BB BIOTECH : statement on MiFID II
EQ
2017BB BIOTECH AG : Product approvals and solid company results lead the biotech sec..
EQ
2017DGAP-ADHOC : BB BIOTECH AG: Tailwind for biotech investors
AQ
More news
Sector news : Biotechnology & Medical Research - NEC
06/13Sanofi says on track to regain solid position in cancer drugs
RE
06/12GSK says vaccine business president to leave by year-end
RE
06/06Drugmaker Lundbeck to settle U.S. charity probe for $52.6 million
RE
06/01Lilly, Incyte Get FDA OK for Lower-Dose Rheumatoid Arthritis Drug
DJ
05/30Gap in regulating biotech drug copies prompts WHO to step in
RE
More sector news : Biotechnology & Medical Research - NEC
Latest Tweets
05/23BB Biotech saw Esperion Therapeutics’s collapse earlier this month as a buyin..
1
05/07BB Biotech scommette  
04/23$BION Biotech AG 2 directors bought: Two Directors at Bb Biotech Ag bought 2.. 
04/23BB BIOTECH AG : Notification and public disclosure of transactions by persons.. 
04/23BB BIOTECH AG : Notification and public disclosure of transactions by persons.. 
More tweets
Qtime:44
News from SeekingAlpha
2016Myovant Sciences IPO Attracts Major Pharma Interest 
2015WINNERS CIRCLE 2014 TOP HEDGE FUND M : Healthcare Funds, Nine Of Top Ten Spots 
Chart BB BIOTECH AG
Duration : Period :
BB BIOTECH AG Technical Analysis Chart | BION | CH0038389992 | 4-Traders
Technical analysis trends BB BIOTECH AG
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 2
Average target price 68,3  CHF
Spread / Average Target 2,5%
EPS Revisions
Managers
NameTitle
Erich Hunziker Chairman
Clive A. Meanwell Vice Chairman
Klaus Strein Director
Claude Mikkelsen Director-Investor Relations
Felicia Flanigan Senior Biotech Analyst
Sector and Competitors
1st jan.Capitalization (M$)
BB BIOTECH AG3.25%3 705
CELLTRION, INC.--.--%33 987
IQVIA HOLDINGS INC5.50%21 394
LONZA GROUP3.38%20 341
INCYTE CORPORATION-22.25%15 677
ALNYLAM PHARMACEUTICALS, INC.-15.15%10 836